Increasing utilization of cancer genetic counseling services using a patient navigator model.
Increasing utilization of cancer genetic counseling services using a patient navigator model.
复制标题
DOI：
10.1007/s10897-006-9051-6
复制
发表时间：
2007-04-01
影响因子：
1.9
通讯作者：
Mouchawar, Judy
中科院分区：
文献类型：
--
作者：
Rahm, Alanna Kulchak;Sukhanova, Anna;Mouchawar, Judy
遗传性乳腺癌和卵巢癌（HBOC）的遗传咨询利用率很少与检测利用率分开研究。在凯撒永久科罗拉多，只有30%的所有成员提到HBOC参加遗传咨询。为了增加遗传咨询预约的数量，在一项为期3个月的随机对照试验中对患者导航方法进行了试点测试。共有125名成员被转介HBOC遗传咨询（55名随机分配到PN，70名随机分配到常规护理）。导航仪辅助会员的转诊利用率为44%，而常规护理组为31%（p=0.16）。患者导航员显著缩短了预约时间，超过80%的导航员辅助成员在转诊日期后不到三个月内接受遗传咨询，而常规护理为32%（p=0.002）。病人导航员的帮助缩短了从转诊到预约HBOC遗传咨询的时间，并可能增加这种服务的利用率。
Rarely has utilization of genetic counseling for Hereditary Breast and Ovarian Cancer (HBOC) been studied separately from utilization of testing. At Kaiser Permanente Colorado, consistently only 30% of all members referred for HBOC attend genetic counseling. To increase the volume of genetic counseling appointments, a patient navigator approach was pilot tested in a randomized-controlled trial over 3 months. A total of 125 members were referred for HBOC genetic counseling (55 randomized to PN, 70 randomized to usual care). Utilization of referrals for Navigator-assisted members was 44%, compared to 31% in the usual care arm (p=0.16). The patient navigator significantly decreased time to appointment, with over 80% of Navigator-assisted members seen for genetic counseling less than three months from referral date, compared to 32% in usual care (p=0.002). patient navigator assistance shortens time from referral to appointment for HBOC genetic counseling, and may increase utilization of such services.